Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasms of Urinary Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Not applicableStudy completedNCT04825834
What this trial is testing

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

Who this might be right for
Lung CancerHead and Neck CancerEsophageal Cancer+7 more
Delfi Diagnostics Inc. 2,992
Large-scale testing (Phase 3)Study completedNCT00625664
What this trial is testing

Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
Sanofi 337
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Not applicableLooking for participantsNCT06310759
What this trial is testing

Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Tampere University Hospital 3,000
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT04316689
What this trial is testing

First-in-human Study of S-588210 (S-488210+S-488211)

Who this might be right for
Lung CancerHead and Neck CancerBladder Cancer+2 more
Shionogi 10
Not applicableStudy completedNCT04944550
What this trial is testing

New Models for the Evaluation of Preclinical Treatment for Urothelial Carcinomas of the Upper Excretory Tract.

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaNephroureterectomyTumor+1 more
Centre Hospitalier Universitaire de Nīmes 20
Testing effectiveness (Phase 2)UnknownNCT03062059
What this trial is testing

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Who this might be right for
Urothelial Carcinoma
National Cancer Center, Korea 134
Not applicableStudy completedNCT03013920
What this trial is testing

CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract CancerUrothelial CarcinomaUreter Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 150
Large-scale testing (Phase 3)Study completedNCT02928406
What this trial is testing

Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 1,004
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT04319757
What this trial is testing

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more
Acepodia Biotech, Inc. 12
Not applicableStudy completedNCT06087016
What this trial is testing

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers

Who this might be right for
Urinary Bladder Tumour
CHU de Reims 899
Not applicableStudy completedNCT04933604
What this trial is testing

LPN in Patients With High-complex Renal Tumors

Who this might be right for
Renal CancerRenal NeoplasmRenal Cell Carcinoma+7 more
Samsun Liv Hospital 78
Early research (Phase 1)Ended earlyNCT04311710
What this trial is testing

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

Who this might be right for
Tumor
Bristol-Myers Squibb 21
Not applicableLooking for participantsNCT03787056
What this trial is testing

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Who this might be right for
CancerBreast CancerGastric Cancer+14 more
Hospices Civils de Lyon 410
Not applicableUnknownNCT03673202
What this trial is testing

The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

Who this might be right for
Bladder Cancer
London Health Sciences Centre 300
Not applicableStudy completedNCT03307200
What this trial is testing

Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy

Who this might be right for
Bladder CancerUrologic CancerSurgery
University Hospital, Ghent 90
Early research (Phase 1)Active Not RecruitingNCT02869217
What this trial is testing

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Who this might be right for
NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive PatientsSynovial SarcomaMelanoma+5 more
University Health Network, Toronto 22
Next Page